Picture of Amphastar Pharmaceuticals, logo

AMPH Amphastar Pharmaceuticals, News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapContrarian

U.S. RESEARCH ROUNDUP-Bluebird Bio, Smiledirectclub, Whitehorse Finance

Aug 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Bluebird Bio, Smiledirectclub and Whitehorse
Finance, on Tuesday. 
    
    HIGHLIGHTS
     * Beacon Roofing Supply Inc  BECN.O : Jefferies cuts to hold from buy
     * Bluebird Bio Inc  BLUE.O : SVB Leerink cuts to market perform from outperform     
     * Select Interior Concepts Inc  SIC.O : Truist Securities cuts to hold from buy
     * Smiledirectclub Inc  SDC.O : JP Morgan cuts to underweight from neutral     
     * Whitehorse Finance Inc  WHF.O : JP Morgan raises to neutral from underweight 
            
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order. 
    
     * Adaptimmune Therapeutics Plc  ADAP.O : SVB Leerink cuts target price to $5 from $6 
     * Amedisys Inc  AMED.O : Raymond James cuts target price to $250 from $325 
     * Amphastar Pharmaceuticals Inc  AMPH.O : Piper Sandler raises target price to $20 from $19 
     * Apellis Pharmaceuticals Inc  APLS.O : Credit Suisse raises target price to $50 from $44 
     * Aterian Inc  ATER.O : Alliance Global Partners cuts target price to $9 from $30 
     * Avadel Pharmaceuticals Plc  AVDL.O : Piper Sandler cuts target price to $14 from $16 
     * Avaya Holdings Corp  AVYA.N : Barclays cuts target price to $28 from $35 
     * Avidity Biosciences Inc  RNA.O : Credit Suisse cuts target price to $36 from $37 
     * Axsome Therapeutics Inc  AXSM.O : SVB Leerink cuts target price to $75 from $115 
     * Aziyo Biologics Inc  AZYO.O : Truist Securities cuts target price to $14 from $16 
     * Bandwidth Inc  BAND.O : Berenberg cuts target price to $179 from $187 
     * Beacon Roofing Supply Inc  BECN.O : Jefferies cuts to hold from buy
     * Beacon Roofing Supply Inc  BECN.O : Jefferies cuts target price to $56 from $69 
     * Bellring Brands Inc  BRBR.N : Stephens raises target price to $39 from $36 
     * Biohaven Pharmaceutical Holding Company Ltd  BHVN.N : Mizuho raises PT to $137 from $134 
     * Biontech SE  BNTX.O : JP Morgan raises target price to $153 from $137 
     * Bluebird Bio Inc  BLUE.O : JP Morgan cuts target price to $37 from $45 
     * Bluebird Bio Inc  BLUE.O : SVB Leerink cuts target price to $20 from $64 
     * Bluebird Bio Inc  BLUE.O : SVB Leerink cuts to market perform from outperform 
     * Boston Properties Inc  BXP.N : JP Morgan raises target price to $110 from $100 
     * Bridge Investment Group Holdings Inc  BRDG.N : JP Morgan initiates with overweight rating
     * Bridge Investment Group Holdings Inc  BRDG.N : JP Morgan initiates with price target $18 
     * Brookfield Asset Management Inc  BAM.N : JP Morgan raises target price to $69 from $62 
     * Brp Group Inc  BRP.O : Jefferies raises target price to $29 from $26 
     * Cable One Inc  CABO.N : Wells Fargo raises target price to $2,400 from $2,210 
     * Callaway Golf Co  ELY.N : B.Riley raises target price to $40 from $38 
     * Callaway Golf Co  ELY.N : Jefferies raises target price to $49 from $45 
     * Cara Therapeutics Inc  CARA.O : Piper Sandler cuts target price to $30 from $32 
     * Cerence Inc  CRNC.O : Jefferies raises target price to $140 from $117 
     * Cerence Inc  CRNC.O : Wells Fargo raises target price to $115 from $108 
     * Cinemark Holdings Inc  CNK.N : JP Morgan cuts target price to $20 from $26 
     * Compass Inc  COMP.N : Barclays raises target price to $20 from $19 
     * Dicerna Pharmaceuticals Inc  DRNA.O : SVB Leerink cuts target price to $34 from $47 
     * Digital Media Solutions Inc  DMS.N : Craig-Hallum cuts target price to $12 from $16 
     * Eagle Pharmaceuticals Inc  EGRX.O : Piper Sandler raises target price to $48 from $46 
     * Edgewise Therapeutics Inc  EWTX.O : JP Morgan raises target price to $35 from $34 
     * Energizer Holdings Inc  ENR.N : JP Morgan cuts target price to $45 from $49 
     * Erasca Inc  ERAS.O : JP Morgan initiates coverage with overweight rating; PT $28 
     * Everbridge Inc  EVBG.O : Raymond James raises target price to $180 from $140 
     * Evercommerce Inc  EVCM.O : Barclays raises target price to $21 from $19 
     * Evercommerce Inc  EVCM.O : Jefferies raises target price to $22 from $19 
     * Evercommerce Inc  EVCM.O : Piper Sandler raises target price to $24 from $22 
     * Evercommerce Inc  EVCM.O : Raymond James raises target price to $24 from $20 
     * FireEye Inc  FEYE.O : CFRA cuts target price by $3 to $20 
     * Fluor Corp  FLR.N : CFRA cuts target price to $20 from $27 
     * Fulgent Genetics Inc  FLGT.O : Credit Suisse raises target price to $65 from $55 
     * Gan Ltd  GAN.O : Jefferies initiates with buy rating and $21 target price 
     * Gates Industrial Corporation Plc  GTES.N : Credit Suisse raises target to $22 from $21 
     * Gladstone Commercial Corp  GOOD.O : Janney raises fair value to $25 
     * Global Blood Therapeutics Inc  GBT.O : JP Morgan raises target price to $38 from $36 
     * Gossamer Bio Inc  GOSS.O : SVB Leerink cuts target price to $15 from $19 
     * Groupon Inc  GRPN.O : Ascendiant Capital Markets cuts target price to $40 from $70 
     * Halozyme Therapeutics Inc  HALO.O : JP Morgan raises target price to $50 from $43 
     * Health Catalyst Inc  HCAT.O : Raymond James raises target price to $70 from $66 
     * Holly Energy Partners LP  HEP.N : Credit Suisse cuts target price to $20 from $21 
     * Immunovant Inc  IMVT.O : SVB Leerink cuts target price to $12 from $17 
     * J2 Global Inc  JCOM.O : JP Morgan raises target price to $175 from $160 
     * Lhc Group Inc  LHCG.O : Credit Suisse cuts target price to $252 from $255 
     * Mack-Cali Realty Corp  CLI.N : JP Morgan raises target price to $18 from $16 
     * Marcus Corp  MCS.N : Barrington Research cuts target price by $3 to $22 
     * Model N Inc  MODN.N : JP Morgan raises target price to $42 from $40 
     * Northrop Grumman Corp  NOC.N : JP Morgan raises target price to $395 from $370 
     * Ocular Therapeutix Inc  OCUL.O : Piper Sandler cuts target price to $27 from $28 
     * Pdl Community Bancorp  PDLB.O : Compass Point raises target price to $17 from $16 
     * Planet Fitness Inc  PLNT.N : Piper Sandler raises target price to $77 from $76 
     * priority Technology Holdings  PRTH.O : Alliance Global Partners cuts PT to $17 from $18.50 
     * Purple Innovation Inc  PRPL.O : B. Riley cuts target price to $34 from $38 
     * Qualys Inc  QLYS.O : RBC raises target price to $112 from $105 
     * Realreal Inc  REAL.O : Piper Sandler cuts target price to $22 from $33 
     * Repay Holdings Corp  RPAY.O : Credit Suisse cuts target price to $30 from $33 
     * Ritchie Bros Auctioneers Inc  RBA.N : National Bank of Canada raises PT to $65 from $62 
     * Rocket Pharmaceuticals Inc  RCKT.O : SVB Leerink cuts target price to $62 from $66 
     * Scientific Games Corp  SGMS.O : Credit Suisse raises target price to $39 from $36 
     * Scientific Games Corp  SGMS.O : JP Morgan raises target price to $69 from $50 
     * Sciplay Corp  SCPL.O : JP Morgan raises target price to $17 from $16 
     * Select Interior Concepts Inc  SIC.O : Truist Securities cuts to hold from buy
     * Select Interior Concepts Inc  SIC.O : Truist Securities raises target to $14.50 from $13 
     * Select Medical Holdings Corp  SEM.N : Credit Suisse raises target price to $39 from $37 
     * Senseonics Holdings Inc  SENS.A : SVB Leerink raises target price to $3 from $2 
     * Shockwave Medical Inc  SWAV.O : Piper Sandler raises target price to $225 from $207 
     * Shockwave Medical Inc  SWAV.O : SVB Leerink raises target price to $220 from $208 
     * Smiledirectclub Inc  SDC.O : JP Morgan cuts target price to $6 from $10 
     * Smiledirectclub Inc  SDC.O : JP Morgan cuts to underweight from neutral 
     * Sohu.com Ltd  SOHU.O : Jefferies raises to buy from hold; raises target to $28 from $23.50 
     * Southwest Gas Holdings Inc  SWX.N : CFRA cuts target price by $1 to $78 
     * Spirit Aerosystems Holdings Inc  SPR.N : JP Morgan raises target price to $54 from $49 
     * Squarespace Inc  SQSP.N : Piper Sandler cuts target price to $50 from $62 
     * Sunoco LP  SUN.N : Credit Suisse raises target price to $37 from $35 
     * Syneos Health Inc  SYNH.O : Baird raises target price to $115 from $113 
     * Syneos Health Inc  SYNH.O : Credit Suisse raises target price to $100 from $96 
     * Syneos Health Inc  SYNH.O : JP Morgan raises target price to $105 from $95 
     * Syneos Health Inc  SYNH.O : Mizuho raises target price to $93 from $90 
     * Targa Resources Corp  TRGP.N : Credit Suisse raises target price to $52 from $46 
     * Theravance Biopharma Inc  TBPH.O : JP Morgan cuts target price to $27 from $30 
     * Trade Desk Inc  TTD.O : CFRA raises target price to $95 from $90 
     * Trade Desk Inc  TTD.O : Jefferies raises target price to $84 from $56 
     * Trade Desk Inc  TTD.O : Oppenheimer raises target price to $95 from $85 
     * Tscan Therapeutics Inc  TCRX.O : Jefferies initiates with buy rating and $21 target price 
     * Tyson Foods Inc  TSN.N : CFRA raises target price by $5 to $82 
     * Tyson Foods Inc  TSN.N : Piper Sandler raises target price to $83 from $79 
     * United Therapeutics Corp  UTHR.O : JP Morgan raises target price to $235 from $211 
     * Vapotherm Inc  VAPO.N : Piper Sandler raises target price to $33 from $32 
     * Velocity Financial Inc  VEL.N : Raymond James raises target price to $17 from $11 
     * Vontier Corp  VNT.N : JP Morgan raises target price to $40 from $37 
     * Whitehorse Finance Inc  WHF.O : JP Morgan raises to neutral from underweight 
     * Whitehorse Finance Inc  WHF.O : Raymond James raises target price to $16.50 from $16 
     * Zillow Group Inc  ZG.O : Stephens cuts target price to $217 from $235 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Amphastar Pharmaceuticals,

See all news